Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination

Alexander J., Najibi, Ryan S., Lane, Miguel C., Sobral, Giovanni, Bovone, Shawn, Kang, Benjamin R., Freedman, Joel, Gutierrez Estupinan, Alberto, Elosegui-Artola, Christina M., Tringides, Maxence O., Dellacherie, Katherine, Williams, Hamza, Ijaz, Sören, Müller, Shannon J., Turley, David J., Mooney

Nature Biomedical Engineering |

Following immunization, lymph nodes dynamically expand and contract. The mechanical and cellular changes enabling the early-stage expansion of lymph nodes have been characterized, yet the durability of such responses and their implications for adaptive immunity and vaccine efficacy are unknown. Here, by leveraging high-frequency ultrasound imaging of the lymph nodes of mice, we report more potent and persistent lymph-node expansion for animals immunized with a mesoporous silica vaccine incorporating a model antigen than for animals given bolus immunization or standard vaccine formulations such as alum, and that durable and robust lymph-node expansion was associated with vaccine efficacy and adaptive immunity for 100 days post-vaccination in a mouse model of melanoma. Immunization altered the mechanical and extracellular-matrix properties of the lymph nodes, drove antigen-dependent proliferation of immune and stromal cells, and altered the transcriptional features of dendritic cells and inflammatory monocytes. Strategies that robustly maintain lymph-node expansion may result in enhanced vaccination outcomes.